Antidiabetic Drug Interactions

Büyükokuroğlu, M. E., Tanyeri, P., & Keleş, R. (2019). İlaç-ilaç etkileşimleri konusunda farkındalık. Online Türk Sağlık Bilimleri Dergisi, 4(3), 377-391.

Drzewoski, J., & Kopff, B. (2000). Clinically important effects of oral antidiabetic drug interactions. Polski merkuriusz lekarski:organ Polskiego Towarzystwa Lekarskiego, 9(51), 605–607.

Scheen, A. J. (2005). Drug interactions of clinical importance with antihyperglycaemic agents: an update. Drug safety, 28, 601-631.

Kelleci Çelik, F., Akkaya, H. (2022). Tıbbi Bitkiler ve İlaç Etkileşimleri. Atatürk Üniversitesi YayıneviISBN: 978-625-7086-39-4.

RxMediaPharma 2023, access date: 10 April 2023.

Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu. Türkiye Endokrinoloji ve Metabolizma Derneği. (2022). 15. Baskı. ANKARA ISBN 978-605-66410-5-3

Aktay, G., Hamit Hancı, İ., & Balseven, A. (2003). İlaç Etkileşimleri ve Hekim Sorumluluğu. Sürekli Tıp Eğitimi Dergisi, 12(7), 261-4.

Bayraktar, M. (2001). Oral hipoglisemikler. Türkiye Tıp Dergisi, 8, 35-44.

Scheen, A. J. (2007). Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide. Clinical pharmacokinetics, 46, 93-108.

Roustit, M., Blondel, E., Villier, C., Fonrose, X., & Mallaret, M. P. (2010). Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient. Annals of Pharmacotherapy, 44(4), 764-767.

Khamaisi, M., & Leitersdorf, E. (2008). Severe hypoglycemia from clarithromycin-repaglinide drug interaction.Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 28(5), 682-684.

Barsbay, E. (2019). Oral antidiyabetiklerde ilaç etkileşimleri (Master’s thesis, İstanbul Medipol Üniversitesi Sağlık Bilimleri Enstitüsü), 1-75.

Scheen, A. J. (2010). Dipeptidylpeptidase-4 Inhibitors (Gliptins) Focus on Drug-Drug Interactions. Clinical pharmacokinetics, 49, 573-588.

Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK) Web site. https://titck.gov.tr/ access date: 14 March 2023.

Garipoğlu, G., & Akbulut, G. (2014) . Tip 2 diabetes mellitus tedavisinde kullanılan oral antidiyabetikler ve besin-ilaç, ilaç-ilaç etkileşimleri. İç Hastalıkları Dergisi, 21(1), 1-9.

Ruan, X. C., Tan, P. Y., & Tan, Y. (2019). Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia. Cureus, 11(6).

Shenfi eld, G. M. (2001). Drug interactions with oral hypoglycaemic drugs. Australian Prescriber, 24, 83-5.

Lai, J. H., Wang, M. T., Wu, C. C., Huang, Y. L., Lu, C. H., & Liou, J. T. (2020). Risk of severe hypoglycemic events from amiodarone-sulfonylureas interactions: a population-based nested case-control study. Pharmacoepidemiology and Drug Safety, 29(8), 842-853.

Niemi, M., Neuvonen, P. J., & Kivistö, K. T. (2001). Effect of gemfi brozil on the pharmacokinetics and pharmacodynamics of glimepiride. Clinical Pharmacology & Therapeutics, 70(5), 439-445.

Seltzer, H. S. (1989). Drug-induced hypoglycemia: a review of 1418 cases. Endocrinology and metabolism clinics of North America, 18(1), 163-183.

Nagaraju, B., & Anilkumar, K. V. (2021). Pharmacodynamic and pharmacokinetic interaction of losartan with glimepiride-metformin combination in rats and rabbits. Indian Journal of Pharmacology, 53(6), 465.

Kalaria, T., Ko, Y. L., & Issuree, K. K. J. (2021). Literature review: Drug and alcohol-induced hypoglycaemia. J. Lab. Precis. Med, 6, 1-16.

Niemi, M., Backman, J. T., Neuvonen, M., Laitila, J., Neuvonen, P. J., & Kivistö, K. T. (2001). Effects of fl uconazole and fl uvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride. Clinical Pharmacology & Therapeutics, 69(4), 194-200.

Gerson M. (1984). Points: Interaction of miconazole and sulphonylureas. British Medical Journal (Clinical research ed.), 288(6412), 243.

Nitin, M., Krunal, S., Rooman, H., Girish, M., & Chetan, M. (2011). Pharmacodynamic Drug Interaction of Imipramine with Glibenclamide in Normal Rabbits. Research Journal of Pharmacology and Pharmacodynamics, 3(3), 129-133.

Takhar, J., & Williamson, P. (1999). Hypoglycemia associated with high doses of sertraline and sulphonylureacompound in a noninsulin-dependent diabetes mellitus patient. The Canadian journal of clinicalpharmacology = Journal canadien de pharmacologie clinique, 6(1), 12–14.

Ramasso, J., & Foglia, V. (1964). Effect Of Sulfonylureas and Mao Inhibitors on the Glycolysis Of Erythrocytes. Revista de la Sociedad Argentina de Biologia, 40, 57-61.

Puckett, W. H., & Visconti, J. A. (1971). An epidemiological study of the clinical signifi cance of drugdrug interactions in a private community hospital. American Journal of Health-System Pharmacy, 28(4), 247–253.

Suresh, D. K., Gavali, M., Ingale, V., Thakar, B., Saifuddin, K., & Rao, R. (2012). Infl uence of Anastrozole on Glimepiride in Experimental Animals. Research Journal of Pharmacology and Pharmacodynamics, 4(4), 236-240.

Deruiter, J. (2003). Overview of the antidiabetic agents. Endocrine Pharmacotherapy Module, 3(3), 45-50.

Moulin, P., Andre, M., Alawi, H., Dos Santos, L. C., Khalid, A. K., Koev, D.,... & Francillard, M. (2006). Effi cacy of benfl uorex in combination with sulfonylurea in type 2 diabetic patients: an 18-week, randomized, double-blind study. Diabetes Care, 29(3), 515-520.

Food and Drug Administration (FDA) Web site. https://www.fda.gov/ access date: 14 March 2023.

Sharma, N., Sim, Y. B., Park, S. H., Lim, S. M., Kim, S. S., Jung, J. S.,... & Suh, H. W. (2015). Effect of sulfonylureas administered centrally on the blood glucose level in immobilization stress model. The Korean Journal of Physiology & Pharmacology: Offi cial Journal of the Korean Physiological Society and the Korean Society of Pharmacology, 19(3), 197.

Türkiye Tıbbi İlaç ve Cihaz Kurumu (TİTCK) Web site. https://titck.gov.tr/ access date: 14 March 2023.

Zia, H., & Price, J. C. (1975). Binding study of sulfonylureas and phenothiazines to bovine serum albumin using difference spectrophotometry. Journal of Pharmaceutical Sciences, 64(7), 1177-1181.

Parameshappa, B., Rao, N.V., Gouda, T.S., Sen, S., Chakraborty, R., Basha, A., Reddy, S., & Kumar, S. (2010). A study on drug-drug interaction between anti-hypertensive drug(propranolol) and anti-diabetic drug (glipizide). Annals of Biological Research, 1, 1-6.

Pakkir Maideen, N. M., Manavalan, G., & Balasubramanian, K. (2018). Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter. Therapeutic advances in endocrinology and metabolism, 9(8), 259-268.

Tuladhar, L. R., Shrestha, S. L., Regmi, D., Bimali, S., Bhusal, S., & Khadka, P. (2021). Drug-drug Interactions between Hypoglycemic and Non-hypoglycemic Medication in Diabetic Patients with Comorbidities in a Tertiary Care Center: A Descriptive Cross-sectional Study. JNMA: Journal of the Nepal Medical Association, 59(243), 1125.

Ren, J., Zhou, Y., Zhang, G., Zhou, L., Zhao, J., Wei, Y., & Wu, X. A. (2015). Role of age-related decrease of renal organic cation transporter 2 in the effect of atenolol on renal excretion of metformin in rats. Europeanjournal of drug metabolism and pharmacokinetics, 40, 349-354.

Saha, S., Begum, R., Rahman, A., Sultan, M. Z., Amran, M. S., & Hossain, M. A. (2013). Evaluation of in vitro interaction of metformin with ibuprofen in aqueous medium. Bangladesh Pharmaceutical Journal, 16(2), 189-194.

Rojas, L. B. A., & Gomes, M. B. (2013). Metformin: an old but still the best treatment for type 2 diabetes. Diabetology & metabolic syndrome, 5(1), 1-15.

Kusuhara, H., Ito, S., Kumagai, Y., Jiang, M., Shiroshita, T., Moriyama, Y.,... & Sugiyama, Y. (2011). Effects of a MATE protein inhibitor, pyrimethamine, on the renal elimination of metformin at oral microdose and at therapeutic dose in healthy subjects. Clinical Pharmacology & Therapeutics, 89(6), 837-844.

Otachi, E. O. (2016). Potential drug-drug interactions among patients with type 2 diabetes and hypertension in Kisii Teaching and Referral Hospital, Kenya (Doctoral dissertation, University of Nairobi).

Naveed, S., & Sadia, H. (2021). Interaction Studies of ACE Inhibitors with Antidiabetic Drugs. In Metformin- Pharmacology and Drug Interactions. IntechOpen.

Arayne, M. S., Sultana, N., Zuberi, M. H., & Haroon, U. (2010). In vitro studies of interaction between metformin and NSAIDS (Non Steroidal Anti-Infl amatory Drugs) using spectrophotometry and RP-High Performance Liquid Chromatography. Journal of the Chilean Chemical Society, 55(2), 206-211.

Akçay, M. N., Akçay, G., & öztürk, G. (2005). The effects of metformin and oral propranolol on insulin resistance in thermally injured patients. The Pain Clinic, 17(2), 189-192.

Maideen, N. M. P. (2018). Thiazolidinediones and their Drug Interactions involving CYP enzymes. American Journal of Physiology, Biochemistry and Pharmacology, 8(2), 1-8.

Janadri, S., Setty, S. R., & Kharya, M. D. (2009). Infl uence of itraconazole on antidiabetic effect of thiazolidinedione in diabetic rats. Int J Pharm Pharmaceutical Sci, 1(1), 119-124.

Niemi, M., Backman, J. T., Granfors, M., Laitila, J., Neuvonen, M., & Neuvonen, P. J. (2003). Gemfi brozil considerably increases the plasma concentrations of rosiglitazone. Diabetologia, 46, 1319-1323.

Niemi, M., Backman, J. T., & Neuvonen, P. J. (2004). Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone. Clinical Pharmacology & Therapeutics, 76(3), 239-249.

Pedersen, R. S., Damkier, P., & Brosen, K. (2006). The effects of human CYP2C8 genotype and fl uvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects. British journal of clinical pharmacology, 62(6), 682-689.

Pradeepkumar, B., Goruntla, N., Chinthaginjala, H., Reddy, K. S., Ahad, A., Sudheer, A., & Raghavendra, M. (2022). Infl uence of trazodone on the pharmacodynamics and pharmacokinetics of pioglitazone. Indian Journal of Pharmacology, 54(3), 194.